Science Explorer Back to mapMap
Discussion
Company · Mississauga · Canada

Gilead Sciences (Canada)

gilead.com/utility/global-operations/north-america/canadaROR OpenAlex
Research works
29
▲ 63% vs 2018-21
Citations
848
29.2 per fractional work
Top-10% rate
10.2%
all institutions 10.0%
Open access
60%
world 40%
International
73%
world 18%
Gilead Sciences (Canada)

Not ranked overall: Gilead Sciences (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Gilead Sciences (Canada) work in?

In all years, 51% of research at Gilead Sciences (Canada) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (15%), Immunology and Microbiology (7%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 15 fractional works · 51.0% of its workMedicine: 14 fractional works · 47.9% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.5% of its workEpidemiology: 2 fractional works · 7.2% of its workOncology: 2 fractional works · 6.3% of its workInfectious Diseases: 2 fractional works · 6.2% of its workPhysiology: 1 fractional works · 3.1% of its workEmergency Medicine: 1 fractional works · 2.5% of its workHepatology: 1 fractional works · 2.4% of its workPathology and Forensic Medicine: 1 fractional works · 2.4% of its workGenetics: 1 fractional works · 2.0% of its workImmunology and Allergy: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.3% of its workRheumatology: 0 fractional works · 1.2% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.7% of its workNephrology: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workReproductive Medicine: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.3% of its workFamily Practice: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workDentistry: 1 fractional works · 2.3% of its workPeriodontics: 1 fractional works · 2.3% of its workHealth Professions: 0 fractional works · 0.6% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workGeneral Health Professions: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 7 fractional works · 24.6% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 14.5% of its workMolecular Biology: 3 fractional works · 9.4% of its workGenetics: 1 fractional works · 2.6% of its workCancer Research: 0 fractional works · 1.0% of its workBiotechnology: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workMolecular Medicine: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 7.1% of its workImmunology: 1 fractional works · 4.9% of its workVirology: 1 fractional works · 2.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.8% of its workPharmaceutical Science: 0 fractional works · 1.4% of its workPharmacology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workFood Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.6% of its workSensory Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 16.3% of its workMathematics: 1 fractional works · 4.2% of its workStatistics and Probability: 1 fractional works · 4.2% of its workEnvironmental Science: 1 fractional works · 3.8% of its workEcology: 1 fractional works · 2.3% of its workEcological Modeling: 0 fractional works · 1.1% of its workEnvironmental Engineering: 0 fractional works · 0.4% of its workChemistry: 1 fractional works · 3.7% of its workSpectroscopy: 0 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workInorganic Chemistry: 0 fractional works · 0.6% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workEngineering: 1 fractional works · 2.3% of its workBuilding and Construction: 0 fractional works · 1.7% of its workOcean Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 1.7% of its workArtificial Intelligence: 0 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workGeophysics: 0 fractional works · 0.4% of its workMaterials Science: 0 fractional works · 0.3% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workSocial Sciences: 2 fractional works · 8.1% of its workSocial Sciences: 1 fractional works · 4.5% of its workTransportation: 0 fractional works · 1.7% of its workHealth: 0 fractional works · 1.1% of its workPolitical Science and International Relations: 0 fractional works · 0.8% of its workSociology and Political Science: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.4% of its workDecision Sciences: 1 fractional works · 2.0% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.1% of its workManagement Science and Operations Research: 0 fractional works · 1.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workPsychology: 0 fractional works · 0.4% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.4% of its workALL ITS WORKGilead Sciences(Canada)29fractional works, all years
Life Sciences25%Physical Sciences16%Health Sciences51%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1447.9%
    2. Dentistry12.3%
    3. Health Professions00.6%
    4. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology414.5%
    2. Immunology and Microbiology27.1%
    3. Pharmacology, Toxicology and Pharmaceutics11.8%
    4. Agricultural and Biological Sciences00.7%
    5. Neuroscience00.6%
    1. Mathematics14.2%
    2. Environmental Science13.8%
    3. Chemistry13.7%
    4. Engineering12.3%
    5. Computer Science01.7%
    6. Earth and Planetary Sciences00.4%
    7. Materials Science00.3%
    1. Social Sciences14.5%
    2. Decision Sciences12.0%
    3. Economics, Econometrics and Finance01.1%
    4. Psychology00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.36× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.70× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.04× its world share, 0 worksImmunology and Micro…Neuroscience: 0.08× its world share, 0 worksNeuroscienceChemistry: 0.97× its world share, 0 worksChemistryComputer Science: 0.49× its world share, 0 worksComputer ScienceEngineering: 0.31× its world share, 0 worksEngineeringEnvironmental Science: 1.84× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 0 worksMaterials ScienceMathematics: 7.78× its world share, 1 worksMathematicsDentistry: 12.58× its world share, 1 worksDentistryHealth Professions: 0.23× its world share, 0 worksHealth ProfessionsMedicine: 2.15× its world share, 4 worksMedicineVeterinary: 2.81× its world share, 0 worksVeterinaryDecision Sciences: 4.51× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.87× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.60× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 12.6×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Dentistry12.58×1 works
  2. Mathematics7.78×1 works
  3. Decision Sciences4.51×0 works
  4. Immunology and Microbiology3.04×0 works
  5. Veterinary2.81×0 works
  6. Medicine2.15×4 works
  7. Environmental Science1.84×1 works
  8. Chemistry0.97×0 works
  9. Economics, Econometrics and Finance0.87×0 works
  10. Biochemistry, Genetics and Molecular Biology0.70×0 works
  11. Social Sciences0.60×1 works
  12. Computer Science0.49×0 works
  13. Agricultural and Biological Sciences0.36×0 works
  14. Engineering0.31×0 works
  15. Health Professions0.23×0 works
  16. Materials Science0.22×0 works
  17. Neuroscience0.08×0 works

What are the most cited papers from Gilead Sciences (Canada)?

The most cited paper from Gilead Sciences (Canada) is "Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults" (Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier et al., 2001), with 335 citations. Next come "Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA" (325) and "Management of adverse events associated with idelalisib treatment: expert panel opinion" (312).

Most cited papers
#PaperReleasedCitations
1 Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier et al. · Antimicrobial Agents and Chemotherapy Open access Oct 2001 335
2 Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9- R -(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA Brian L. Robbins, Ranga V. Srinivas, Choung Kim et al. · Antimicrobial Agents and Chemotherapy Open access Mar 1998 325
3 Management of adverse events associated with idelalisib treatment: expert panel opinion Steven E. Coutre, Jacqueline C. Barrientos, Jennifer R. Brown et al. · Leukemia & lymphoma/Leukemia and lymphoma Open access 2 Mar 2015 312
4 ACG Clinical Guideline: Liver Disease and Pregnancy Tram T. Tran, Joseph C. Ahn, Nancy S. Reau · The American Journal of Gastroenterology Feb 2016 309
5 Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC) Kalyan Kumar Das, Xiao‐Feng Xiong, Huiling Yang et al. · Journal of Virology Open access 15 May 2001 276
All 99 most cited papers, with filters and sorting

Which keywords describe research at Gilead Sciences (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Antiretroviral Therapy, Epidemiology, HIV Infection, Inflammation, Lymphoma, Immune Response, Immunotherapy and Cancer Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Epidemiology4▲ 3.5×19 topics
  2. Antiretroviral Therapy4▲ 53×5 topics
  3. Inflammation3▲ 4.0×16 topics
  4. HIV Infection2▲ 57×2 topics
  5. Lymphoma2▲ 47×2 topics
  6. Immune Response2▲ 10×9 topics
  7. Cancer2▲ 4.1×13 topics
  8. Treatment2▲ 4.5×4 topics
  9. Immunotherapy2▲ 8.6×3 topics
  10. Cancer Immunotherapy1▲ 35×3 topics
  11. CAR T Cells1▲ 107×1 topic
  12. Chimeric Antigen Receptor1▲ 107×1 topic
  13. Drug Resistance1▲ 14×1 topic
  14. Integrase Inhibitors1▲ 109×1 topic
  15. HIV1▲ 34×3 topics
  16. Rituximab1▲ 27×2 topics
  17. Asthma1▲ 30×2 topics
  18. Climate Change1▲ 1.37×3 topics
  19. Genetics1▲ 4.7×4 topics

Which research topics does Gilead Sciences (Canada) publish most on?

By volume in 2022-now: HIV/AIDS drug development and treatment, CAR-T cell therapy research, HIV-related health complications and treatments and Traffic Prediction and Management Techniques.

HIV/AIDS drug developmen…1HIV/AIDS drug development and treatment: 1 fractional worksCAR-T cell therapy resea…1CAR-T cell therapy research: 1 fractional worksHIV-related health compl…1HIV-related health complications and treatments: 1 fractional worksTraffic Prediction and M…0Traffic Prediction and Management Techniques: 0 fractional worksHuman Mobility and Location-Based Analysis: 0 fractional worksStatistical Methods and Bayesian Inference: 0 fractional worksStatistical Methods and …0Statistical Methods and Inference: 0 fractional worksAvian ecology and behavior: 0 fractional worksStreptococcal Infections and Treatments: 0 fractional worksOral Health Pathology and Treatment: 0 fractional works
Infectious DiseasesOncologyEmergency MedicineBuilding and Construction5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 HIV-related health complications and treatments Emergency Medicine 1 works
  4. 4 Traffic Prediction and Management Techniques Building and Construction 0 works
  5. 5 Human Mobility and Location-Based Analysis Transportation 0 works
  6. 6 Statistical Methods and Bayesian Inference Statistics and Probability 0 works
  7. 7 Statistical Methods and Inference Statistics and Probability 0 works
  8. 8 Avian ecology and behavior Ecology 0 works
  9. 9 Streptococcal Infections and Treatments Public Health, Environmental and Occupational Health 0 works
  10. 10 Oral Health Pathology and Treatment Periodontics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available59.7%not open40.3%

World: 40% of research is openly available.

with international co-authors73.0%domestic only27.0%

World: 18% is written across borders.

How has Gilead Sciences (Canada)'s research output changed?

Output in 2022-2025 was 63% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Gilead Sciences (Canada) as a percentage of every work published that year, 0.000038% in 2024.

still counting0.000050%0.00010%Gilead Sciences (Canada)0.000063% in 2025200020102020

Fractional works of Gilead Sciences (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Gilead Sciences (Canada). Posts are plain text and can be reported.